Tommy Fornander

Tommy Fornander

UNVERIFIED PROFILE

Are you Tommy Fornander?   Register this Author

Register author
Tommy Fornander

Tommy Fornander

Publications by authors named "Tommy Fornander"

Are you Tommy Fornander?   Register this Author

67Publications

1207Reads

27Profile Views

The effects of PTPN2 loss on cell signalling and clinical outcome in relation to breast cancer subtype.

J Cancer Res Clin Oncol 2019 Jul 25;145(7):1845-1856. Epub 2019 Apr 25.

Division of Clinical Sciences, Department of Clinical and Experimental Medicine and Department of Oncology, Faculty of Health Sciences, Linköping University, 581 85, Linköping, Sweden.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00432-019-02918-y
Publisher Site
http://dx.doi.org/10.1007/s00432-019-02918-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571101PMC
July 2019

PTPN2 deficiency along with activation of nuclear Akt predict endocrine resistance in breast cancer.

J Cancer Res Clin Oncol 2019 Mar 4;145(3):599-607. Epub 2018 Dec 4.

Department of Clinical and Experimental Medicine, Department of Oncology, Linköping University, 58185, Linköping, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-018-2810-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394658PMC
March 2019

Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer.

Breast Cancer Res Treat 2018 Feb 11;168(1):17-27. Epub 2017 Nov 11.

Department of Clinical and Experimental Medicine, and Department of Oncology, Linköping University, Linköping, Sweden.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-017-4508-x
Publisher Site
http://dx.doi.org/10.1007/s10549-017-4508-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847064PMC
February 2018

Tamoxifen therapy benefit for patients with 70-gene signature high and low risk.

Breast Cancer Res Treat 2017 Nov 4;166(2):593-601. Epub 2017 Aug 4.

Department of Biosciences and Nutrition, Karolinska Institutet, Hälsovägen 7, 141 83, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4428-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668340PMC
November 2017

[Adverse reactions to anti-hormonal therapy affects adherence].

Lakartidningen 2017 02 14;114. Epub 2017 Feb 14.

Södersjukhuset - Stockholm, Sweden - onkologkliniken Stockholm, Sweden.

View Article

Download full-text PDF

Source
February 2017

High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancer.

J Pathol Clin Res 2017 Jan 14;3(1):38-43. Epub 2016 Sep 14.

Department of Oncology-Pathology Cancer Center Karolinska, Karolinska Institutet Stockholm Sweden.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cjp2.56
Publisher Site
http://dx.doi.org/10.1002/cjp2.56DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259559PMC
January 2017

Risk of hospitalisation and death due to bone fractures after breast cancer: a registry-based cohort study.

Br J Cancer 2016 Nov 4;115(11):1400-1407. Epub 2016 Oct 4.

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobelsväg 12A, Stockholm SE-171 77, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2016.314DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129831PMC
November 2016

Progesterone receptor positivity is a predictor of long-term benefit from adjuvant tamoxifen treatment of estrogen receptor positive breast cancer.

Breast Cancer Res Treat 2016 11 8;160(2):313-322. Epub 2016 Oct 8.

Department of Clinical and Experimental Medicine, Division of Oncology, Linköping University, Linköping, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-4007-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065613PMC
November 2016

Met and its ligand HGF are associated with clinical outcome in breast cancer.

Oncotarget 2016 Jun;7(24):37145-37159

Department of Clinical and Experimental Medicine and Department of Oncology, Linköping University, Linköping, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.9268DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095065PMC
June 2016

Can breast cancer register data on recommended adjuvant treatment be used as a proxy for actually given treatment?

Eur J Oncol Nurs 2016 Jun 27;22:1-7. Epub 2016 Feb 27.

Division of Insurance Medicine, Department of Clinical Neuroscience, Karolinska Institutet, 171 77 Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejon.2016.02.010DOI Listing
June 2016

EPH/ephrin profile and EPHB2 expression predicts patient survival in breast cancer.

Oncotarget 2016 Apr;7(16):21362-80

Department of Clinical and Experimental Medicine, Division of Oncology, Linköping University, Linköping, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.7246DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008291PMC
April 2016

ERRα Is a Marker of Tamoxifen Response and Survival in Triple-Negative Breast Cancer.

Clin Cancer Res 2016 Mar 5;22(6):1421-31. Epub 2015 Nov 5.

Department of Biology; Stern College for Women of Yeshiva University; New York, New York. Department of Molecular Pharmacology, Albert Einstein College of Medicine, New York, New York. Albert Einstein Cancer Center; Albert Einstein College of Medicine; Bronx, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-0857DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794381PMC
March 2016

Androgen receptor expression predicts beneficial tamoxifen response in oestrogen receptor-α-negative breast cancer.

Br J Cancer 2016 Feb 7;114(3):248-55. Epub 2016 Jan 7.

Division of Clinical sciences, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Linköping S-581 85, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2015.464DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742586PMC
February 2016

HER4 tumor expression in breast cancer patients randomized to treatment with or without tamoxifen.

Int J Oncol 2015 Oct 28;47(4):1311-20. Epub 2015 Jul 28.

Faculty of Medicine and Health, School of Health and Medical Sciences, Örebro University, SE-701 82 Örebro, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo.2015.3108DOI Listing
October 2015

Loss of protein tyrosine phosphatase, non-receptor type 2 is associated with activation of AKT and tamoxifen resistance in breast cancer.

Breast Cancer Res Treat 2015 Aug 25;153(1):31-40. Epub 2015 Jul 25.

Department of Clinical and Experimental Medicine, and Department of Oncology, Linköping University, 58185, Linköping, Sweden,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-015-3516-yDOI Listing
August 2015

S6 kinase signaling: tamoxifen response and prognostic indication in two breast cancer cohorts.

Endocr Relat Cancer 2015 Jun;22(3):331-43

Department of Clinical and Experimental MedicineDepartment of OncologyDepartment of Clinical and Experimental MedicineDivision of Dermatology, Linköping University, SE-58185 Linköping, SwedenDepartment of OncologyKarolinska University Hospital, Karolinska Institute, SE-17176 Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-14-0513DOI Listing
June 2015

C-X-C ligand 10 and C-X-C receptor 3 status can predict tamoxifen treatment response in breast cancer patients.

Breast Cancer Res Treat 2014 May 9;145(1):73-82. Epub 2014 Apr 9.

Division of Surgery and Clinical Oncology, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, 581 85, Linköping, Sweden,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-014-2933-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984417PMC
May 2014

Akt2 expression is associated with good long-term prognosis in oestrogen receptor positive breast cancer.

Eur J Cancer 2013 Apr 8;49(6):1196-204. Epub 2013 Jan 8.

Regional Cancer Center, Southeast Sweden, County Council of Östergötland, Linköping, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2012.12.006DOI Listing
April 2013

Wwox expression may predict benefit from adjuvant tamoxifen in randomized breast cancer patients.

Oncol Rep 2013 Apr 31;29(4):1467-74. Epub 2013 Jan 31.

School of Health and Medical Sciences, Örebro University, SE-70182 Örebro, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2013.2261DOI Listing
April 2013

Effects of adjuvant tamoxifen therapy on cardiac disease: results from a randomized trial with long-term follow-up.

Breast Cancer Res Treat 2013 Apr 2;138(2):467-73. Epub 2013 Mar 2.

Regional Cancer Centre, County Council of Östergötland, University Hospital, 581 85, Linköping, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-013-2457-6DOI Listing
April 2013

17β-Hydroxysteroid dehydrogenase type 14 is a predictive marker for tamoxifen response in oestrogen receptor positive breast cancer.

PLoS One 2012 6;7(7):e40568. Epub 2012 Jul 6.

Division of Oncology, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0040568PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3391289PMC
January 2013

Placental weight and mortality in premenopausal breast cancer by tumor characteristics.

Breast Cancer Res Treat 2013 Jan 13;137(1):297-305. Epub 2012 Nov 13.

Clinical Epidemiology Unit, Department of Medicine, Karolinska Institutet, 171 76 Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-012-2337-5DOI Listing
January 2013

Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit.

Breast Cancer Res Treat 2013 Jan 15;137(2):397-406. Epub 2012 Dec 15.

Division of Oncology, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University & County Council of Östergötland, SE-581 85, Linköping, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-012-2376-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539073PMC
January 2013

Impact of comorbidity on management and mortality in women diagnosed with breast cancer.

Breast Cancer Res Treat 2012 Aug 26;135(1):281-9. Epub 2012 Jul 26.

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, PO Box 281, 171 77 Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-012-2176-4DOI Listing
August 2012

Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based study.

Breast Cancer Res Treat 2012 May;133(1):367-73

Regional Cancer Centre, Uppsala University Hospital, 751 85 Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-012-1961-4DOI Listing
May 2012

Age-specific trends of survival in metastatic breast cancer: 26 years longitudinal data from a population-based cancer registry in Stockholm, Sweden.

Breast Cancer Res Treat 2011 Nov 27;130(2):553-60. Epub 2011 May 27.

Department of Oncology-Pathology, Radiumhemmet, Karolinska Institutet, Karolinska University Hospital, 17176 Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-011-1594-zDOI Listing
November 2011

Work status and life changes in the first year after breast cancer diagnosis.

Work 2011 ;38(4):337-46

Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden Department of Oncology, Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/WOR-2011-1137DOI Listing
October 2011

Clinical potential of the mTOR targets S6K1 and S6K2 in breast cancer.

Breast Cancer Res Treat 2011 Aug 16;128(3):713-23. Epub 2010 Oct 16.

Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-010-1058-xDOI Listing
August 2011

Interaction between goserelin and tamoxifen in a prospective randomised clinical trial of adjuvant endocrine therapy in premenopausal breast cancer.

Breast Cancer Res Treat 2011 Aug 29;128(3):755-63. Epub 2011 May 29.

Department of Oncology, Karolinska Institutet and University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-011-1593-0DOI Listing
August 2011

Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen.

Breast Cancer Res Treat 2011 Apr 19;126(2):421-30. Epub 2010 Oct 19.

Department of Oncology, Karolinska University Hospital, Karolinska Institute, Södersjukhuset, 11883, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-010-1202-7DOI Listing
April 2011

Predictive relevance of HOXB13 protein expression for tamoxifen benefit in breast cancer.

Breast Cancer Res 2010 22;12(4):R53. Epub 2010 Jul 22.

Department of Clinical and Experimental Medicine, Division of Oncology, Faculty of Health Sciences, Linköping University, SE-58185 Linköping, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr2612DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949642PMC
March 2011

Low expression of Ku70/80, but high expression of DNA-PKcs, predict good response to radiotherapy in early breast cancer.

Int J Oncol 2010 Dec;37(6):1547-54

Department of Clinical and Experimental Medicine, Division of Surgery and Clinical Oncology, Linköping University, Linköping, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo_00000808DOI Listing
December 2010

Reductions in use of hormone replacement therapy: effects on Swedish breast cancer incidence trends only seen after several years.

Breast Cancer Res Treat 2010 Jun 6;121(3):679-83. Epub 2009 Nov 6.

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, PO Box 281, 171 77 Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-009-0615-7
Publisher Site
http://dx.doi.org/10.1007/s10549-009-0615-7DOI Listing
June 2010

The impact of RNA standardization and heterogeneous gene expression on the results of cDNA array of human breast carcinoma.

Int J Mol Med 2010 May;25(5):735-41

Department of Oncology, Karolinska University Hospital, Södersjukhuset, S-118 83 Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijmm_00000399DOI Listing
May 2010

Estrogen receptor-alpha phosphorylation at serine 305, nuclear p21-activated kinase 1 expression, and response to tamoxifen in postmenopausal breast cancer.

Clin Cancer Res 2010 Mar 23;16(5):1624-33. Epub 2010 Feb 23.

Division of Surgery and Clinical Oncology, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linkoping University, Linkoping, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-09-1733DOI Listing
March 2010

Ratio of 17HSD1 to 17HSD2 protein expression predicts the outcome of tamoxifen treatment in postmenopausal breast cancer patients.

Clin Cancer Res 2009 May 28;15(10):3610-6. Epub 2009 Apr 28.

Department of Clinical and Experimental Medicine, Division of Oncology, Linköping University, Linköping, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-2599DOI Listing
May 2009

Long-term effectiveness of adjuvant goserelin in premenopausal women with early breast cancer.

J Natl Cancer Inst 2009 Mar 24;101(5):341-9. Epub 2009 Feb 24.

Cancer Research UK & UCL Cancer Trials Centre, University College London, 90 Tottenham Court Rd, London W1T 4TJ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djn498DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2650713PMC
March 2009

Altered expression of cyclin E and the retinoblastoma protein influences the effect of adjuvant therapy in breast cancer.

Int J Oncol 2009 Feb;34(2):441-8

Linköping University, Faculty of Health Sciences, Department of Clinical and Experimental Medicine, KEF/oncology laboratory, University Hospital, SE-581 85 Linköping, Sweden.

View Article

Download full-text PDF

Source
February 2009

Predictors of return to work ten months after primary breast cancer surgery.

Acta Oncol 2009 ;48(1):93-8

Karolinska Institutet, Department of Oncology and Pathology, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/02841860802477899DOI Listing
January 2009

Long-term pattern of disease recurrence among patients with early-stage breast cancer according to estrogen receptor status and use of adjuvant tamoxifen.

Breast Cancer Res Treat 2008 Jan 15;107(1):71-8. Epub 2007 Feb 15.

Department of oncology, Karolinska University Hospital, Söder Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-007-9520-0DOI Listing
January 2008

Family history, and impact on clinical presentation and prognosis, in a population-based breast cancer cohort from the Stockholm County.

Fam Cancer 2006 1;5(4):309-21. Epub 2006 Jul 1.

Department of Oncology, Karolinska University Hospital at Södersjukhuset, S 118 83, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10689-006-7851-3
Publisher Site
http://dx.doi.org/10.1007/s10689-006-7851-3DOI Listing
September 2007

The BRCA1/BRCA2/Rad51 complex is a prognostic and predictive factor in early breast cancer.

Radiother Oncol 2007 Sep 17;84(3):242-51. Epub 2007 Aug 17.

Department of Biomedicine and Surgery, Linköping University, Linköping, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2007.06.012DOI Listing
September 2007

Factors associated with return to work after breast cancer treatment.

Acta Oncol 2007 ;46(1):90-6

Department of Oncology, Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/02841860600857318DOI Listing
May 2007

Time-dependent RNA degradation affecting cDNA array quality in spontaneous canine tumours sampled using standard surgical procedures.

Int J Mol Med 2005 Dec;16(6):979-85

Department of Small Animal Clinical Sciences, Swedish University of Agricultural Sciences (SLU), Uppsala, Sweden.

View Article

Download full-text PDF

Source
December 2005

Concentration of thymidine kinase 1 in serum (S-TK1) is a more sensitive proliferation marker in human solid tumors than its activity.

Oncol Rep 2005 Oct;14(4):1013-9

Department of Oncology Clinic Research Laboratory, KFC, floor 5, Karolinska University Hospital, S-141 86 Stockholm, Sweden.

View Article

Download full-text PDF

Source
October 2005

BRCA1 mutations in a population-based study of breast cancer in Stockholm County.

Genet Test 2004 ;8(2):127-32

Department of Oncology, Huddinge University Hospital, Södersjukhuset, S 118 83 Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/gte.2004.8.127DOI Listing
February 2005

Radiation-induced cell cycle response in lymphocytes is not related to clinical side-effects in breast cancer patients.

Anticancer Res 2003 May-Jun;23(3C):3077-83

Department of Oncology-Pathology, Karolinska Institutet and Hospital, SE-171 76 Stockholm, Sweden.

View Article

Download full-text PDF

Source
September 2003

Side effects of adjuvant endocrine treatment in premenopausal breast cancer patients: a prospective randomized study.

J Clin Oncol 2003 May;21(9):1836-44

Unit of Psychosocial Oncology and Rehabilitation, Karolinska Hospital, S-171 76, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2003.04.024DOI Listing
May 2003